BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23791549)

  • 1. Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.
    Faria E; Turturro F; Rao P; Matin SF
    Clin Genitourin Cancer; 2013 Dec; 11(4):e1-5. PubMed ID: 23791549
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic tumor response to everolimus for malignant epithelioid angiomyolipoma.
    Shitara K; Yatabe Y; Mizota A; Sano T; Nimura Y; Muro K
    Jpn J Clin Oncol; 2011 Jun; 41(6):814-6. PubMed ID: 21415002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal angiomyolipomatosis and Kaposi's sarcoma: a possible link disrupted by sirolimus.
    Stallone G; Infante B; Tartaglia L; Bruno F; Gesualdo L; Grandaliano G
    Intern Emerg Med; 2012 Sep; 7 Suppl 2():S127-9. PubMed ID: 22915080
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of mammalian target of rapamycin inhibitor in the treatment of metastatic epithelioid angiomyolipoma: a case report.
    Kohno J; Matsui Y; Yamasaki T; Shibasaki N; Kamba T; Yoshimura K; Sumiyoshi S; Mikami Y; Ogawa O
    Int J Urol; 2013 Sep; 20(9):938-41. PubMed ID: 23347205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab.
    Alexandru S; Gonzalez E; Grande C; Hernandez A; Morales E; Praga M; Andres A; Morales JM
    Transplant Proc; 2009; 41(6):2435-7. PubMed ID: 19715944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus and temsirolimus for epithelioid angiomyolipoma.
    Wolff N; Kabbani W; Bradley T; Raj G; Watumull L; Brugarolas J
    J Clin Oncol; 2010 Feb; 28(5):e65-8. PubMed ID: 20048172
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell lymphoma manifesting as a uvular mass.
    Lai WS; Wang CH; Shih CP
    Rheumatology (Oxford); 2013 Apr; 52(4):608. PubMed ID: 23264553
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant renal epithelioid angiomyolipoma with liver metastasis after resection: a case report with multimodality imaging and review of the literature.
    Vicens RA; Jensen CT; Korivi BR; Bhosale PR
    J Comput Assist Tomogr; 2014; 38(4):574-7. PubMed ID: 24887578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoglobulinemic Glomerulonephritis Associated With Nodal and Renal Infiltration by T-Cell Lymphoma of T-Follicular Helper Phenotype: A Case Report.
    Li J; Umakanathan M; P'ng CH; Varikatt W; Kwok F; Lin MW; Vucak-Dzumhur M
    Am J Kidney Dis; 2018 Oct; 72(4):606-611. PubMed ID: 29784613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
    Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
    Babb A; Zerizer I; Naresh KN; Macdonald D
    Am J Hematol; 2011 Apr; 86(4):375-6. PubMed ID: 21442643
    [No Abstract]   [Full Text] [Related]  

  • 12. Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression.
    Wen MC; Jan YJ; Li MC; Wang J; Lin A
    Pathology; 2010 Apr; 42(3):300-2. PubMed ID: 20350230
    [No Abstract]   [Full Text] [Related]  

  • 13. Everolimus for renal angiomyolipoma in tuberous sclerosis.
    Sooriakumaran P; Anderson CJ
    Lancet; 2013 Mar; 381(9869):783-5. PubMed ID: 23312828
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete regression of cardiac non-Hodgkin lymphoma.
    Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
    Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment to role of mammalian target of rapamycin inhibitor in the treatment of metastatic epithelioid angiomyolipoma: a case report.
    Nagashima Y
    Int J Urol; 2013 Sep; 20(9):942. PubMed ID: 23379352
    [No Abstract]   [Full Text] [Related]  

  • 16. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
    Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
    Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis.
    Bujalance-Cabrera C; Vaquero-Barrios JM; Redel-Montero J; Caballero-Ballesteros L; Requejo-Jiménez A; Santos-Luna F
    Arch Bronconeumol; 2012 Dec; 48(12):479-81. PubMed ID: 22444789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
    Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
    Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.
    Gennatas C; Michalaki V; Kairi PV; Kondi-Paphiti A; Voros D
    World J Surg Oncol; 2012 Sep; 10():181. PubMed ID: 22943457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular infiltration by intravascular large B-cell lymphoma.
    Tian C; Wang X; Zhang Y
    Br J Haematol; 2016 Sep; 174(6):833. PubMed ID: 27391281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.